Pulmonary toxicity following administration of granulocyte colony-stimulating factor during chemotherapy for breast cancer: a case report and literature review

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

In this report, we aim to present a case of pulmonary toxicity in a patient that received neoadjuvant chemotherapy treatment with doxorubicin and cyclophosphamide for triple-negative breast cancer that was followed with granulocyte colony-stimulating factor (G-CSF) for prevention neutropenia, our patient presented with chest discomfort and dyspnea, with radiologic evidence of radiologic investigations showed acute respiratory distress syndrome, after investigation and follow up we came to the conclusion that it was G-CSF adverse effect.

Original languageEnglish
Pages (from-to)1142-1145
Number of pages4
JournalAnti-Cancer Drugs
Volume32
Issue number10
DOIs
StatePublished - 1 Nov 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • breast cancer
  • chemotherapy
  • granulocyte colony-stimulating factor
  • lung toxicity
  • neutropenic fever

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Pulmonary toxicity following administration of granulocyte colony-stimulating factor during chemotherapy for breast cancer: a case report and literature review'. Together they form a unique fingerprint.

Cite this